Axinn Advised Columbia Care in its $240M Acquisition of Green Leaf Medical
May 3, 2021
Axinn represented Columbia Care, a market leader in the two largest cannabis markets in the world (California and Colorado) in its acquisition of Green Leaf Medical, a privately held, fully-integrated cannabis multi-state operator based in the mid-Atlantic region for $240 million with the potential for additional performance-based milestone payments. Announced on December 22, 2020, the acquisition of Green Leaf will expand Columbia Care’s operational scale and footprint in four key, limited license markets by materially enhancing the scale and capabilities of its seed-to-sale operations. The deal closed on June 11, 2021.
The Axinn team was led by Lisl Dunlop and assisted by associate Sam Sherman.
Related Services
To subscribe to our publications, click here.
Featured Insights
Featured Insights
GCR Live: Law Leaders Global 2025
Speaking Engagement
Antitrust
Evidence for Trial Lawyers: Motions, Introducing Evidence, and Objections
Speaking Engagement
Intellectual Property
NYC Bar Trade Secrets Symposium 2024: Navigating the Law of Trade Secrets and Restrictive Covenants
Speaking Engagement
Intellectual Property
Stakeholders 24th Annual CYOC Career Development Conference
Sponsorship
IAM Connect Patent Policy and Litigation Conference 2024
Speaking Engagement
Intellectual Property
CompLaw 33rd Annual Advanced EU Brussels Conference
Speaking Engagement
Jason Murata Named a Profiles in Diversity Journal Diverse Lawyers Making a Difference Award Winner
Awards & Recognitions
Intellectual Property
AIC General Counsel Day 2024
Speaking Engagement
Antitrust
ALM General Counsel Conference East 2024
Speaking Engagement
Antitrust
Global M&A Antitrust Outlook: Trends Shaping Enforcement Strategies
Speaking Engagement
Antitrust
